Research Topics
| K A AultSummaryAffiliation: University of Iowa Country: USA Publications
| Collaborators
|
Detail Information
Publications
Antibodies to the chlamydial 60 kilodalton heat shock protein in women with tubal factor infertilityK A Ault
Department of Obstetrics and Gynecology, University of Kansas Medical Center, Kansas City, USA
Infect Dis Obstet Gynecol 6:163-7. 1998..Our objective was to study the relationship between antibody response to 60 kilodalton chlamydial hsp and tubal factor infertility (TFI)...
A phase I study to evaluate a human papillomavirus (HPV) type 18 L1 VLP vaccineKevin A Ault
Department of Obstetrics and Gynecology, University of Iowa Hospitals and Clinics, 200 Hawkins Drive, Iowa City, IA 52242, USA
Vaccine 22:3004-7. 2004..Peak anti-HPV18 geometric mean titers (GMT) in vaccines were 60-fold greater than those observed in women following natural HPV18 infection. Further studies of a multivalent HPV L1 VLP vaccines are warranted...
Human papillomavirus infections: diagnosis, treatment, and hope for a vaccineKevin A Ault
Department of Obstetrics and Gynecology, University of Iowa Hospitals and Clinics, 200 Hawkins Drive, Iowa City, IA 52242, USA
Obstet Gynecol Clin North Am 30:809-17. 2003..Gynecologists should be familiar with these therapies and their potential short-comings. A recently reported clinical trial has raised hopes that HPV and its sequelae may be prevented by vaccination...
Gonorrhea and chlamydia infection among women visiting family planning clinics: racial variation in prevalence and predictorsLisa A Einwalter
University of Iowa, College of Public Health, Iowa City, IA, USA
Perspect Sex Reprod Health 37:135-40. 2005..Because of the potential impact of these infections on women's reproductive health, it is important to determine whether different factors are predictive of infection in women of different races...
Gynecologists' attitudes regarding human papilloma virus vaccination: a survey of Fellows of the American College of Obstetricians and GynecologistsJanice C Raley
Department of Obstetrics and Gynecology, University of Iowa Hospitals and Clinics, Iowa City, IA 52242, USA
Infect Dis Obstet Gynecol 12:127-33. 2004..CONCLUSION: Professional society recommendation is important for acceptability of a potential HPV vaccine. Gynecologists are willing to include this vaccine in their office practice...
Does rubella immunity predict measles immunity? A serosurvey of pregnant womenColleen M Kennedy
Department of Obstetrics and Gynecology, Roy J and Lucille A Carver College of Medicine, University of Iowa Hospitals and Clinics, Iowa City, IA 52242, USA
Infect Dis Obstet Gynecol 2006:13890. 2006..This study was undertaken to determine whether rubella immunity infers measles immunity in pregnant women...
Telomerase activity as a potential diagnostic marker for triage of abnormal Pap smearsKevin A Ault
Department of Obstetrics and Gynecology, University of Iowa, Iowa City, Iowa, USA
J Low Genit Tract Dis 9:93-9. 2005..These results warrant larger studies to determine whether telomerase activity may be a useful triage tool for abnormal cytologic findings...
Chlamydia trachomatis enhances the expression of matrix metalloproteinases in an in vitro model of the human fallopian tube infectionKevin A Ault
Department of Obstetrics and Gynecology, University of Iowa College of Medicine, Iowa City, USA
Am J Obstet Gynecol 187:1377-83. 2002..Enhanced matrix metalloproteinase production in some individuals in response to infection may lead to tubal scarring through the increased turnover and subsequent repair of the extracellular matrix...
Surfactant proteins A and D enhance the phagocytosis of Chlamydia into THP-1 cellsRebecca E Oberley
Department of Anatomy and Cell Biology, University of Iowa College of Medicine, Iowa City, IA 52242, USA
Am J Physiol Lung Cell Mol Physiol 287:L296-306. 2004..In addition, the chlamydial pathogens internalized in the presence of collectins are able to grow and replicate in the THP-1 cells after phagocytosis...
Surfactant protein D is present in the human female reproductive tract and inhibits Chlamydia trachomatis infectionRebecca E Oberley
Department of Anatomy and Cell Biology, University of Iowa, Carver College of Medicine, Iowa City, IA 52242, USA
Mol Hum Reprod 10:861-70. 2004..In conclusion, we detected SP-D in the female reproductive tract and determined that one of the functions of the SP-D protein may be to protect cervical epithelial cells from infection by C. trachomatis...
A role for surfactant protein D in innate immunity of the human prostateRebecca E Oberley
Department of Anatomy and Cell Biology, University of Iowa College of Medicine, Iowa City, Iowa 52242, USA
Prostate 65:241-51. 2005..SP-D protein levels are increased at sites of inflammation in the prostate, suggesting SP-D may also contribute more generally to inflammatory regulation in the prostate...
Epidemiology and natural history of human papillomavirus infections in the female genital tractKevin A Ault
Department of Gynecology and Obstetrics, Emory University School of Medicine, Atlanta, GA 30303, USA
Infect Dis Obstet Gynecol 2006:40470. 2006..New prophylactic HPV vaccines promise to dramatically reduce the incidence of HPV infection, genital warts, and cytologic abnormalities...
Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18Luisa L Villa
Department of Virology, Ludwig Institute for Cancer Research, R Prof Antonio Prudente 109, 4th Floor, 01509 010 Sao Paulo, SP, Brazil
Vaccine 24:5571-83. 2006..Following an initial, similar sized decline, anti-HPV responses plateaued and remained stable through end-of-study (3.0 years). No vaccine-related serious adverse experiences were reported...
Efficacy of human papillomavirus-16 vaccine to prevent cervical intraepithelial neoplasia: a randomized controlled trialConstance Mao
Department of Obstetrics and Gynecology and Epidemiology, University of Washington, Seattle, Washington 98104 2499, USA
Obstet Gynecol 107:18-27. 2006..Whether protection lasts longer than 18 months and, thus, impacts rates of cervical intraepithelial neoplasia (CIN) 2-3 has not yet been established. We present results from an HPV16 L1 VLP vaccine trial through 48 months...
Vaccines for the prevention of human papillomavirus and associated gynecologic diseases: a reviewKevin A Ault
Department of Gynecology and Obstetrics, Emory University School of Medicine, Atlanta, Georgia, USA
Obstet Gynecol Surv 61:S26-31. 2006....
Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trialLuisa L Villa
Department of Virology, Ludwig Institute for Cancer Research, Sao Paulo, Brazil
Lancet Oncol 6:271-8. 2005....
A controlled trial of a human papillomavirus type 16 vaccineLaura A Koutsky
Department of Epidemiology, University of Washington, Seattle, USA
N Engl J Med 347:1645-51. 2002..Although most infections are benign, some progress to anogenital cancer. A vaccine that reduces the incidence of HPV-16 infection may provide important public health benefits...
Human papillomavirus vaccines and the potential for cross-protection between related HPV typesKevin A Ault
Division of Gynecologic Oncology, Department of Gynecology and Obstetrics, Emory University School of Medicine, 69 Jesse Hill Jr Drive, S E Atlanta, Georgia 30303, USA
Gynecol Oncol 107:S31-3. 2007..Over a period of 6 months, cross-protection was observed against persistent infections with HPV-45, -31 and -52, and at 12 months, modest protection was demonstrated against persistent infections with 12 combined oncogenic HPV types...
Regulation of surfactant protein D in the mouse female reproductive tract in vivoRebecca E Oberley
Department of Medicine, National Jewish Medical and Research Center, Denver, CO 80206, USA
Mol Hum Reprod 13:863-8. 2007..These data are suggestive that SP-D may play a role in innate immunity in the female reproductive tract in vivo...
Long-term efficacy of human papillomavirus vaccinationKevin A Ault
Division of Gynecologic Oncology, Department of Gynecology and Obstetrics, Emory University School of Medicine, 69 Jesse Hill Drive, Atlanta, GA 30064, USA
Gynecol Oncol 107:S27-30. 2007..Population-based long-term efficacy trials conducted in these countries aim to investigate the long-term efficacy of HPV vaccination with regard to invasive cervical cancer, and the results of these trials are awaited with interest...
Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trialsKevin A Ault
Department of Gynecology and Obstetrics, Emory University School of Medicine, 69 Jesse Hill Jr Drive, SE, Atlanta, GA 30303, USA
Lancet 369:1861-8. 2007..In this combined analysis of four clinical trials we assessed the effect of prophylactic HPV vaccination on these diseases...
Modeling the long-term antibody response of a human papillomavirus (HPV) virus-like particle (VLP) type 16 prophylactic vaccineChristophe Fraser
Imperial College London, London, UK
Vaccine 25:4324-33. 2007....
Imiquimod does not affect shedding of viable chlamydiae in a murine model of Chlamydia trachomatis genital tract infectionKyle H Ramsey
Department of Microbiology, Chicago College of Osteopathic Medicine, Midwestern University, Downers Grove, IL 60515, USA
Infect Dis Obstet Gynecol 11:81-7. 2003..We postulated that either oral or vaginal administration of the immune response modifier imiquimod would decrease vaginal shedding of Chlamydia trachomatis, mouse pneumonitis strain (MoPn), in a murine model...
Human papillomavirus vaccines: an update for gynecologistsKevin A Ault
Department of Gynecology and Obstetrics, Emory University School of Medicine, Atlanta, Georgia, USA
Clin Obstet Gynecol 51:527-32. 2008..This review will discuss the natural history and epidemiology of HPV, the diseases associated with these infections and current clinical usage of this vaccine. Future developments in this area will also be discussed...
